Brief: Auven Therapeutics announces sale of Ocular Technologies to Sun Pharma

Sun Pharma Advanced Research

26/10/2016 16:38

Oct 26 (Reuters) - Auven Therapeutics  
    * Auven Therapeutics announces sale of Ocular Technologies 
to Sun Pharma 
    * Auven Therapeutics-sale of 100 percent of Ocular 
Technologies Sarl to a wholly owned subsidiary of Sun 
Pharmaceutical Industries Ltd 
    * Auven Therapeutics- co will receive an upfront payment of 
$40 million plus substantial contingent development and sales 
milestones 
 
Source text : ID:nGNXNKKPAa  
 
 ((Bangalore.newsroom@thomsonreuters.com;))